- Exchange: EN Paris
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for Sanofi (SAN)
| Open: | 85.0000 | Day's Range: | 84.0900 - 85.6400 | Volume: | 2,341,080 |
|---|---|---|---|---|---|
| Previous Close: | 84.5100 | 52wk Range: | 53.2000 - 86.4300 | 1-Yr Rtn: | +59.24% |
Key Statistics for SAN
| Current P/E Ratio (ttm) | 22.4761 |
|---|---|
| Estimated P/E(12/2013) | 14.3627 |
| Relative P/E vs. CAC | 1.7124 |
| Earnings Per Share (EUR) (ttm) | 3.7600 |
| Est. EPS (EUR) (12/2013) | 5.8840 |
| Est. PEG Ratio | 2.0728 |
| Market Cap (M EUR) | 111,896.15 |
| Shares Outstanding (M) | 1,324.06 |
| 30 Day Average Volume | 2,843,057 |
| Price/Book (mrq) | 1.9503 |
| Price/Sale (ttm) | 3.1909 |
| Dividend Indicated Gross Yield | 3.28% |
| Cash Dividend (EUR) | 2.7700 |
| Last Dividend | 05/09/2013 |
| 5 Year Dividend Growth | 6.00% |
| Next Earnings Announcement | 07/26/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for SAN
Company Profile & Key Executives for SAN
Sanofi is a global pharmaceutical company that researches, develops and manufactures prescription pharmaceuticals and vaccines. The Company develops cardiovascular, thrombosis, metabolic disorder, central nervous system, internal medicine and oncology drugs, and vaccines.
| Serge Daniel WeinbergChairman | Christopher A Viehbacher "Chris"Chief Executive Officer |
| Hanspeter SpekPres:Global Operations | Elias A ZerhouniPres:Global Research & Dev |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
SAN News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page